tiprankstipranks
Trending News
More News >
Collegium Pharmaceutical (COLL)
NASDAQ:COLL
US Market

Collegium Pharmaceutical (COLL) Income Statement

Compare
484 Followers

Collegium Pharmaceutical Income Statement

Last quarter (Q3 2025), Collegium Pharmaceutical's total revenue was $209.36M, an increase of 31.42% from the same quarter last year. In Q3, Collegium Pharmaceutical's net income was $31.51M. See Collegium Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 631.45M$ 566.77M$ 463.93M$ 276.87M$ 310.02M
Gross Profit
$ 377.34M$ 326.17M$ 209.49M$ 150.62M$ 179.84M
Operating Expenses
$ 207.45M$ 159.21M$ 176.17M$ 132.99M$ 123.60M
Depreciation and Amortization
$ 169.16M$ 149.26M$ 138.94M$ 68.92M$ 61.55M
EBITDA
$ 341.70M$ 308.33M$ 173.31M$ 86.56M$ 118.01M
Operating Income
$ 169.90M$ 166.96M$ 33.32M$ 17.63M$ 56.23M
Other Income/Expenses
$ -71.33M$ -91.23M$ -62.17M$ -21.00M$ -28.65M
Pretax Income
$ 98.57M$ 75.73M$ -28.85M$ -3.37M$ 27.58M
Net Income
$ 69.19M$ 48.16M$ -25.00M$ 71.52M$ 26.75M
Per Share Metrics
Basic EPS
$ 2.14$ 1.60$ -0.74$ 2.05$ 0.78
Diluted EPS
$ 1.86$ 1.29$ -0.74$ 1.86$ 0.76
Weighted Average Shares Outstanding
32.27M 33.74M 33.83M 34.94M 34.41M
Weighted Average Shares Outstanding (Diluted)
40.42M 41.79M 33.83M 41.05M 35.15M
Currency in USD

Collegium Pharmaceutical Earnings and Revenue History